전자 처방전 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 제품별(솔루션), 서비스별, 전문 분야별, 제공 형태별, 물질별, 지역별, 경쟁별 세분화(2020-2030년)

The Global E-Prescribing Market, valued at USD 2.94 Billion in 2024, is projected to experience a CAGR of 8.39% to reach USD 4.77 Billion by 2030. E-prescribing refers to the electronic generation, transmission, and fulfillment of medical prescriptions, replacing traditional paper-based methods to enhance efficiency and patient safety. The market's expansion is fundamentally driven by the increasing adoption of integrated electronic health record solutions, governmental initiatives promoting digital health, and a critical need to mitigate medication errors and combat controlled substance abuse.

Key Market Drivers

The increasing adoption of integrated Electronic Health Record (EHR) systems fundamentally drives the global e-prescribing market by establishing a digital infrastructure for prescription workflows. When e-prescribing is embedded within comprehensive EHR platforms, healthcare providers access patient histories, allergy information, and medication lists, enabling informed and safer prescribing. This integration boosts clinical efficiency and care coordination, streamlining the entire medication management process.

Key Market Challenges

A significant challenge impeding the global e-prescribing market expansion is the persistent issue of interoperability. Disparate electronic health record and pharmacy systems frequently lack seamless communication capabilities, resulting in fragmented patient data and substantial inefficiencies. This fragmentation creates data silos, preventing comprehensive patient information exchange necessary for accurate and safe medication management across the healthcare continuum.

Key Market Trends

The market is observing a significant trend in the integration of AI-powered clinical decision support systems, moving beyond conventional rule-based alerts to embed sophisticated artificial intelligence and machine learning capabilities. These advanced systems are engineered to analyze extensive patient data, including comprehensive medical histories, genomic information, and real-time biometric inputs, to generate highly personalized treatment recommendations. This enables prescribers to anticipate potential drug interactions with enhanced accuracy, identify subtle disease progression patterns, and tailor medication regimens precisely to individual patient needs. The integration of such intelligent tools signifies a fundamental shift towards a more proactive and data-driven approach to patient care, where decision support is not merely reactive but predictive.

Key Market Players

• Oracle Corporation
• Veradigm LLC
• Epic Systems Corporation
• Athenahealth, Inc.
• NextGen Healthcare, Inc.
• McKesson Corporation
• Surescripts, LLC
• Change Healthcare LLC
• Practice Fusion, Inc.
• Networking Technology, Inc.

Report Scope:

In this report, the Global E-Prescribing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

E-Prescribing Market, By Product:

• Solutions
• Services

E-Prescribing Market, By Specialties:

• Oncology
• Sports Medicine
• Neurology
• Cardiology
• Others

E-Prescribing Market, By Delivery Mode:

• Web/Cloud Based
• On Premise

E-Prescribing Market, By Substances:

• Controlled Substances
• Non-controlled Substances

E-Prescribing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global E-Prescribing Market.

Available Customizations:

Global E-Prescribing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global E-Prescribing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Solutions, Services)
  • 5.2.2. By Specialties (Oncology, Sports Medicine, Neurology, Cardiology, Others)
  • 5.2.3. By Delivery Mode (Web/Cloud Based, On Premise)
  • 5.2.4. By Substances (Controlled Substances, Non-controlled Substances)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America E-Prescribing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Specialties
  • 6.2.3. By Delivery Mode
  • 6.2.4. By Substances
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States E-Prescribing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Specialties
      • 6.3.1.2.3. By Delivery Mode
      • 6.3.1.2.4. By Substances
  • 6.3.2. Canada E-Prescribing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Specialties
      • 6.3.2.2.3. By Delivery Mode
      • 6.3.2.2.4. By Substances
  • 6.3.3. Mexico E-Prescribing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Specialties
      • 6.3.3.2.3. By Delivery Mode
      • 6.3.3.2.4. By Substances

7. Europe E-Prescribing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Specialties
  • 7.2.3. By Delivery Mode
  • 7.2.4. By Substances
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany E-Prescribing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Specialties
      • 7.3.1.2.3. By Delivery Mode
      • 7.3.1.2.4. By Substances
  • 7.3.2. France E-Prescribing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Specialties
      • 7.3.2.2.3. By Delivery Mode
      • 7.3.2.2.4. By Substances
  • 7.3.3. United Kingdom E-Prescribing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Specialties
      • 7.3.3.2.3. By Delivery Mode
      • 7.3.3.2.4. By Substances
  • 7.3.4. Italy E-Prescribing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Specialties
      • 7.3.4.2.3. By Delivery Mode
      • 7.3.4.2.4. By Substances
  • 7.3.5. Spain E-Prescribing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Specialties
      • 7.3.5.2.3. By Delivery Mode
      • 7.3.5.2.4. By Substances

8. Asia Pacific E-Prescribing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Specialties
  • 8.2.3. By Delivery Mode
  • 8.2.4. By Substances
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China E-Prescribing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Specialties
      • 8.3.1.2.3. By Delivery Mode
      • 8.3.1.2.4. By Substances
  • 8.3.2. India E-Prescribing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Specialties
      • 8.3.2.2.3. By Delivery Mode
      • 8.3.2.2.4. By Substances
  • 8.3.3. Japan E-Prescribing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Specialties
      • 8.3.3.2.3. By Delivery Mode
      • 8.3.3.2.4. By Substances
  • 8.3.4. South Korea E-Prescribing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Specialties
      • 8.3.4.2.3. By Delivery Mode
      • 8.3.4.2.4. By Substances
  • 8.3.5. Australia E-Prescribing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Specialties
      • 8.3.5.2.3. By Delivery Mode
      • 8.3.5.2.4. By Substances

9. Middle East & Africa E-Prescribing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Specialties
  • 9.2.3. By Delivery Mode
  • 9.2.4. By Substances
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia E-Prescribing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Specialties
      • 9.3.1.2.3. By Delivery Mode
      • 9.3.1.2.4. By Substances
  • 9.3.2. UAE E-Prescribing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Specialties
      • 9.3.2.2.3. By Delivery Mode
      • 9.3.2.2.4. By Substances
  • 9.3.3. South Africa E-Prescribing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Specialties
      • 9.3.3.2.3. By Delivery Mode
      • 9.3.3.2.4. By Substances

10. South America E-Prescribing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Specialties
  • 10.2.3. By Delivery Mode
  • 10.2.4. By Substances
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil E-Prescribing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Specialties
      • 10.3.1.2.3. By Delivery Mode
      • 10.3.1.2.4. By Substances
  • 10.3.2. Colombia E-Prescribing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Specialties
      • 10.3.2.2.3. By Delivery Mode
      • 10.3.2.2.4. By Substances
  • 10.3.3. Argentina E-Prescribing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Specialties
      • 10.3.3.2.3. By Delivery Mode
      • 10.3.3.2.4. By Substances

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global E-Prescribing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Oracle Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Veradigm LLC
• 15.3. Epic Systems Corporation
• 15.4. Athenahealth, Inc.
• 15.5. NextGen Healthcare, Inc.
• 15.6. McKesson Corporation
• 15.7. Surescripts, LLC
• 15.8. Change Healthcare LLC
• 15.9. Practice Fusion, Inc.
• 15.10. Networking Technology, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer